Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price dropped 2.6% during trading on Tuesday . The stock traded as low as $41.33 and last traded at $41.33. Approximately 1,515 shares traded hands during trading, a decline of 38% from the average daily volume of 2,431 shares. The stock had previously closed at $42.45.
Hikma Pharmaceuticals Stock Performance
The business’s 50-day moving average price is $41.66 and its two-hundred day moving average price is $46.30.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Wall Street Alert: Buy AES
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
